ARTICLE | Clinical News
THVD-201: Phase I data
April 4, 2011 7:00 AM UTC
An Australian Phase I trial in 17 healthy volunteers showed that THVD-201 was safe and improved salivary output and related dry mouth side effects compared to Detrol LA tolterodine from Pfizer Inc. ...